A comprehensive view of new use. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Abbott announces approval in Japan to expand reimbursement coverage for its FreeStyle Libre system to include all people with diabetes who use insulin at least once a day; device is a continuous glucose monitoring system

Novavax announces emergency use authorization for Novavax protein-based COVID-19 vaccine for adolescents aged 12 to 18 in India; vaccine is manufactured and marketed in India by Serum Institute of India under the brand Covovax

Merck announces FDA approval of Keytruda intravenous infusion as a single agent for treatment of advanced endometrial carcinoma

Moderna submits request to the FDA for amendment to the emergency use authorization of its mRNA COVID-19 vaccine in adults, to allow for a fourth dose; broad approval will allow CDC, health care providers to determine who should receive a booster dose

Pfizer and BioNTech submit application to FDA for Emergency Use Authorization of an additional COVID-19 vaccine booster for adults aged 65 and older; application is based on real-world data from Israel when Omicron variant was circulating

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count